NICE on lipid modification: NICE has overestimated cardiovascular risk

Comment

Richard G Richards. BMJ. 2008.

. 2008 Jun 14;336(7657):1323-4.

doi: 10.1136/bmj.39605.518287.3A.

No abstract available

Conflict of interest statement

Competing interests: None declared.

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Hippisley-Cox J, et al. BMJ. 2007 Jul 21;335(7611):136. doi: 10.1136/bmj.39261.471806.55. Epub 2007 Jul 5. BMJ. 2007. PMID: 17615182 Free PMC article.
Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance.
Cooper A, O'Flynn N; Guideline Development Group. Cooper A, et al. BMJ. 2008 May 31;336(7655):1246-8. doi: 10.1136/bmj.39554.624086.AD. BMJ. 2008. PMID: 18511800 Free PMC article. Review. No abstract available.

1. Cooper A, O’Flynn N, on behalf of the Guideline Development Group. Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance. BMJ 2008;336:1246-8. (31 May.) - PMC - PubMed
1. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335;136-41. - PMC - PubMed